SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
4	Statement of changes in beneficial ownership of securities	Jan 5, 2005	View HTML 0001179110-05-000584.pdf 0001179110-05-000584.rtf 0001179110-05-000584.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2005	View HTML 0001179110-05-000585.pdf 0001179110-05-000585.rtf 0001179110-05-000585.xls
4	Statement of changes in beneficial ownership of securities	Jan 5, 2005	View HTML 0001179110-05-000597.pdf 0001179110-05-000597.rtf 0001179110-05-000597.xls
4	Statement of changes in beneficial ownership of securities	Jan 4, 2005	View HTML 0001179110-05-000220.pdf 0001179110-05-000220.rtf 0001179110-05-000220.xls
4	Statement of changes in beneficial ownership of securities	Jan 4, 2005	View HTML 0001179110-05-000221.pdf 0001179110-05-000221.rtf 0001179110-05-000221.xls
4	Statement of changes in beneficial ownership of securities	Jan 4, 2005	View HTML 0001179110-05-000222.pdf 0001179110-05-000222.rtf 0001179110-05-000222.xls
8-K	Report of unscheduled material events or corporate event	Nov 12, 2004	View HTML 0001104659-04-035139.pdf 0001104659-04-035139.rtf 0001104659-04-035139.xls
4	Statement of changes in beneficial ownership of securities	Nov 9, 2004	View HTML 0001179110-04-020998.pdf 0001179110-04-020998.rtf
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 9, 2004	View HTML 0001104659-04-034681.pdf 0001104659-04-034681.rtf 0001104659-04-034681.xls
8-A12G	Registration of certain classes of securities 12(g) of the Securities Exchange Act	Nov 8, 2004	View HTML 0001047469-04-033435.pdf 0001047469-04-033435.rtf 0001047469-04-033435.xls

Data provided by Kaleidoscope.